All posts by: Michael Zand

Positive Interim Data Published for Transfusion-Dependent Β-Thalassemia Gene Therapy – AJMC.com Managed Markets Network

Positive Interim Data Published for Transfusion-Dependent Β-Thalassemia Gene TherapyAJMC.com Managed Markets NetworkKelly Davio. Bluebird bio, Inc, has announced the publication of positive interim data for its gene therapy to eliminate or reduce chron… Continue reading

Stem cells from adults function just as well as those from embryos – Science Daily

Stem cells from adults function just as well as those from embryosScience DailyDonor age does not appear to influence the functionality of stem cells derived from adult body tissues, concludes a new review. The analysis of research on induced pluripote… Continue reading

Combination Immunotherapy Treatment Looks Promising for Mesothelioma – Mesothelioma.com

Combination Immunotherapy Treatment Looks Promising for MesotheliomaMesothelioma.comBoston, Massachusetts – Researchers at the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital discovered a novel immunotherapy combination treatme… Continue reading

Research shows possible new target for immunotherapy for solid tumors – Medical Xpress

Medical XpressResearch shows possible new target for immunotherapy for solid tumorsMedical XpressResearch from the University of Cincinnati (UC) reveals a potential new target to help T cells (white blood cells) infiltrate certain solid tumors. This st… Continue reading

Immunotherapy’s Role in TNBC May Be in Combination – OncLive

Agilis Biotherapeutics Presents Platform Paper on AADC Deficiency Gene Therapy at American Academy of Neurology … – Business Wire (press release)

Business Wire (press release)Agilis Biotherapeutics Presents Platform Paper on AADC Deficiency Gene Therapy at American Academy of Neurology …Business Wire (press release)LYNNFIELD, Mass.–(BUSINESS WIRE)–Agilis Biotherapeutics, Inc. (Agilis), a bio… Continue reading

High-Grade Endometrioid Endometrial Cancers Likely to Benefit from Immunotherapy – Curetoday.com

High-Grade Endometrioid Endometrial Cancers Likely to Benefit from ImmunotherapyCuretoday.comPatients with high-grade endometrioid endometrial cancer may benefit from immunotherapy treatment compared with women with lower-grade disease, according to st… Continue reading